2024
DOI: 10.1128/mbio.01049-24
|View full text |Cite
|
Sign up to set email alerts
|

Brincidofovir inhibits polyomavirus infection in vivo

Arrienne B. Butic,
Zoe E. Katz,
Ge Jin
et al.

Abstract: Polyomaviruses are species-specific DNA viruses that can cause disease in immunocompromised individuals. Despite their role as the causative agents for several diseases, there are no currently approved antivirals for treating polyomavirus infection. Brincidofovir (BCV) is an antiviral approved for the treatment of poxvirus infections and has shown activity against other double-stranded DNA viruses. In this study, we tested the efficacy of BCV against polyomavirus infection in vitro … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 83 publications
0
0
0
Order By: Relevance